help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on July 17, 2003
Endocrinology, doi:10.1210/en.2003-0357
A more recent version of this article appeared on October 1, 2003
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
144/10/4626    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mohammad, H. P
Right arrow Articles by Nilson, J. H
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mohammad, H. P
Right arrow Articles by Nilson, J. H
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ESTRADIOL

Submitted on March 24, 2003
Accepted on July 7, 2003

Targeted Overexpression of Luteinizing Hormone Causes Ovary Dependent Functional Adenomas Restricted to Cells of the Pit-1 Lineage

Helai P Mohammad1, Rula A Abbud1, Al F Parlow1, Jonathan S Lewin1, and John H Nilson1*

1 Department of Pharmacology, Case Western Reserve University, Cleveland, OH, 44106; National Hormone and Pituitary Program, Harbor-UCLA Medical Center, Torrance, CA 90509, Radiology and Oncology, University Hospitals of Cleveland and Case Western Reserve University, Cleveland, OH, 44106

* To whom correspondence should be addressed. E-mail: jhn{at}cwru.edu.

The majority of pituitary adenomas in humans are non-metastasizing, monoclonal neoplasms that occur in approximately 20% of the general population. Their development has been linked to a combination of extrinsic factors and intrinsic defects. We now demonstrate, with transgenic mice, that targeted and chronic overexpression of LH (LH) causes ovarian hyperstimulation and subsequent hyperproliferation of Pit-1 positive cells that culminates in the appearance of functional pituitary adenomas ranging from focal to multifocal expansion of lactotropes, somatotropes, and thyrotropes. Tumors fail to develop in ovariectomized mice indicating that contributions from the ovary are necessary for adenoma development. While the link between chronic ovarian hyperstimulation and PRL-secreting adenomas was expected, the involvement of somatotropes and thyrotropes was surprising and suggests that multiple ovarian hormones may contribute to this unusual pathological consequence. In support of this notion, we have found that ovariectomy followed by estrogen replacement results in expansion of lactotropes, selectively in LH overexpressing mice, but not somatotropes and thyrotropes. Collectively, these data indicate that estrogen is sufficient for formation of lactotrope adenomas only in animals with a hyperstimulated ovary whereas appearance of GH- and TSH-adenomas depends on multiple ovarian hormones. Together, our data expand current models of pituitary tumorigenesis by suggesting that chronic ovarian hyperstimulation may underlie formation of a subset of pituitary adenomas containing lactotropes, somatotropes and thyrotropes.


Key words: LH • pituitary adenoma • transgenic mice • ovarian hyperstimulation




This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
R. A. Abbud, I. Takumi, E. M Barker, S.-G. Ren, D.-Y. Chen, K. Wawrowsky, and S. Melmed
Early Multipotential Pituitary Focal Hyperplasia in the {alpha}-Subunit of Glycoprotein Hormone-Driven Pituitary Tumor-Transforming Gene Transgenic Mice
Mol. Endocrinol., May 1, 2005; 19(5): 1383 - 1391.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
H. P. Mohammad, D. D. Seachrist, C. C. Quirk, and J. H. Nilson
Reexpression of p8 Contributes to Tumorigenic Properties of Pituitary Cells and Appears in a Subset of Prolactinomas in Transgenic Mice that Hypersecrete Luteinizing Hormone
Mol. Endocrinol., October 1, 2004; 18(10): 2583 - 2593.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. S. Jorgensen, C. C. Quirk, and J. H. Nilson
Multiple and Overlapping Combinatorial Codes Orchestrate Hormonal Responsiveness and Dictate Cell-Specific Expression of the Genes Encoding Luteinizing Hormone
Endocr. Rev., August 1, 2004; 25(4): 521 - 542.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society